Morgan Stanley upgraded Teradyne (TER) to Equal Weight from Underweight with a price target of $100, up from $74, after its Q2 earnings beat. The stock rose on the back of optimistic commentary on the prospects of penetrating Nvidia (NVDA) beyond their existing position, Morgan Stanley noted. Commentary on Compute opportunity was also more bullish than expected, and while the firm is taking a “conservative stance”, the optionality should support shares near term, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TER:
- Teradyne’s Strong Semiconductor Testing Performance and Strategic Partnerships Justify Buy Rating
- Teradyne price target raised to $130 from $100 at TD Cowen
- Early notable gainers among liquid option names on July 30th
- Teradyne reports Q2 non-GAAP EPS 57c, consensus 54c
- Teradyne sees Q3 EPS 69c-87c, consensus 89c